Efficacy of Medication in Adults With Friedreich Ataxia


The purpose of this study is to evaluate the efficacy of a study drug on arms and hands motor function and manual dexterity. It is also to evaluate the drug on various neurological functions, safety, and tolerability.


  • The study involves approximately 6 visits over 3 months
  • Participants will take a study medication or a placebo
  • Visits will include questionnaires, an electrocardiogram (ECG), medical exams, blood and urine tests, movement tests


  • 18-55 years old
  • Diagnosed with Freidreich's Ataxia
  • BMI between 16 and 40


18 to 65



Monetary compensation



Friedreich's ataxia, Ataxia, Friedreich ataxia, Spinocerebellar degeneration, Central nervous system

Principal Investigator

S.H. Subramony, MD


Department of Neurology

Contact Information


(352) 294-8948

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams